DFX Intelligence

Data Factory

Private creditBorrowerdrug discovery & developmentaunknown

Kura Oncology, Inc

sponsor (inference, pe portfolio stem): Avoro Capital Advisors LLC

Search this name across graphsid dfx:pc:cf7e8370-204a-30e3-480f-31a00f7cabac

Data as of Jun 30, 2026 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 19, 2026, 8:18 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 7
On other graphs: 1
Observed: Dec 31, 2022 to Jun 30, 2026
3 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Kura Oncology, Inc.

name equal in sponsor portfolio · confidence 95% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 1
BDCs: 1
Facilities: 3
Principal, latest: $5.5Mpieces as filed; a lower bound
Fair value, latest: $6.4M
Mark ratio: 102%fair value over cost, latest
Next maturity: Nov 1, 2027
First on a schedule: Dec 31, 2022
Last on a schedule: Jun 30, 2026
Sponsor basis: pe_portfolio_steminferencedeal party is a fact; a portfolio stem or a Form D signer is an inference

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
Term loan	First lien	$5.5M	$5.8M	Nov 1, 2027	Html schedule	0	n/a	1	1	Unknown	Jun 30, 2026
Common equity	equity	n/a	$525,000	n/a	n/a	n/a	n/a	1	1	Unknown	Jun 30, 2026
warrant	equity	n/a	$19,000	n/a	n/a	n/a	n/a	1	1	Unknown	Jun 30, 2026

Lenders holding it now

each BDC's own pieces on its latest schedule, folded to one row per lender; every amount is that BDC's piece as filed, so a sum is a lower bound; 3 rows folded into 1

BDC	Pieces	Principal	Fair value	Unfunded	Nearest maturity	As of
Hercules Capital, Inc.	3	$5.5M	$6.4M	$0	Nov 1, 2027	Jun 30, 2026

Relationships

Sponsors (1)

← Avoro Capital Advisors LLCSponsor of borrowersPE portfolio stem
Sep 14, 2026 to presentinferenceDFX's own graph

Dated events

5 bookkeeping events (roster, classification and holdings changes) folded below

Scheduled
Nov 1, 2027
Facility matures inside 24 months
Kura Oncology, Inc term loan (first lien) matures 2027-11-01 (inside 18 months; $5.5M held by 1 BDC)
Avoro Capital Advisors LLCBDC schedule of investments
$5.5M
Scheduled
Nov 1, 2027
Facility matures inside 24 months
Kura Oncology, Inc term loan (first lien) matures 2027-11-01 (inside 24 months; $5.5M held by 1 BDC)
Avoro Capital Advisors LLCBDC schedule of investments
$5.5M

Show 5 bookkeeping events

Occurred
Mar 31, 2026
Hercules Capital, Inc.: principal decreased in Kura Oncology, Inc ($5.5M principal)
Occurred
Dec 31, 2025
Hercules Capital, Inc.: principal increased in Kura Oncology, Inc ($11.0M principal)
Occurred
Mar 31, 2024
Hercules Capital, Inc.: principal decreased in Kura Oncology, Inc ($5.5M principal)
Occurred
Dec 31, 2023
Hercules Capital, Inc.: principal increased in Kura Oncology, Inc ($11.0M principal)
Occurred
Jun 30, 2023
Hercules Capital, Inc.: new position in Kura Oncology, Inc

Provenance

Graph: Private Credit
Canonical id: dfx:pc:cf7e8370-204a-30e3-480f-31a00f7cabac
First observed: Dec 31, 2022
Last observed: Jun 30, 2026 2 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Kura Oncology, Inc

sponsor (inference, pe portfolio stem): Avoro Capital Advisors LLC

Search this name across graphsid dfx:pc:cf7e8370-204a-30e3-480f-31a00f7cabac

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

Term loan

First lien

$5.5M

$5.8M

Nov 1, 2027

Html schedule

n/a

Unknown

Jun 30, 2026

Common equity

equity

n/a

$525,000

n/a

Unknown

Jun 30, 2026

warrant

equity

n/a

$19,000

n/a

Unknown

Jun 30, 2026

BDC

Pieces

Principal

Fair value

Unfunded

Nearest maturity

As of

Hercules Capital, Inc.

$5.5M

$6.4M

Nov 1, 2027

Jun 30, 2026